Who makes Ketamine via BAN?

Ketamine via BAN is developed by Antonios Likourezos.

What development phase is Ketamine via BAN in?

Ketamine via BAN is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Ketamine via BAN

Antonios Likourezos · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Ketamine via BAN
Sponsor	Antonios Likourezos
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Nebulized vs. IV Ketamine in Preventing Shivering Post Spinal Anesthesia (NA)
Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED (PHASE4)
Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain (PHASE4)
Pre-hospital Nebulized Ketamine for Pain (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ketamine via BAN CI brief — competitive landscape report
Ketamine via BAN updates RSS · CI watch RSS
Antonios Likourezos portfolio CI